adjuvant capecitabine did not significantly improve outcomes for early-stage tnbc
Published 5 years ago • 170 plays • Length 14:24Download video MP4
Download video MP3
Similar videos
-
7:47
adjuvant capecitabine did not significantly improve outcomes for breast cancer patients
-
4:42
results from adding adjuvant capecitabine to treatment for breast cancer patients
-
1:27
what to do in patients with early-stage tnbc who have not achieved a pcr?
-
4:12
no boost in os with addition of capecitabine for early tnbc
-
5:21
optimal neoadjuvant and adjuvant therapy for patients with early tnbc
-
0:42
embracing neo-adjuvant chemotherapy for better outcomes in triple negative breast cancer
-
13:11
capecitabine monotherapy doesn't improve survival in elderly patients with early-stage breast cancer
-
17:21
ctdna detection after neoadjuvant ct significantly associated with disease recurrence in early tnbc
-
3:09
keynote-522: neoadjuvant and adjuvant pembrolizumab for early tnbc
-
7:15
pathologic complete response rates improved with the neoadjuvant and adjuvant treatment of pembr...
-
2:17
atezolizumab with adjuvant chemotherapy for early-stage triple negative breast cancer
-
4:28
for residual tnbc post-chemo, capecitabine should be offered
-
4:35
adjuvant avelumab versus control does not significantly improve dfs but does improve os in high-...
-
23:39
educational sessions: "io vs capecitabine for tnbc"
-
21:36
treatment planning for triple negative breast cancer | 2022 evolution conference
-
20:46
session 10: neoadjuvant and adjuvant treatment of patients with tnbc (javier cortes, spain)
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
0:53
enhancing triple negative breast cancer treatment with immunotherapy across all settings
-
27:03
triple negative breast cancer: predictive and prognostic biomarkers for neo/adjuvant therapy